Literature DB >> 225277

Induction of virus-neutralizing antibody by glycoproteins isolated from chicken cells infected with a herpesvirus of turkeys.

A P Wyn-Jones, O R Kaaden.   

Abstract

The production of virus-induced proteins in chicken embryo fibroblast cells infected with a herpesvirus of turkeys was studied. It was found that glycoproteins isolated from membrane-rich fractions of infected cells by affinity chromatography using concanavalin A induced neutralizing and precipitating antibody in rabbits and chickens. After analytical electrophoresis, such isolates were found to contain three polypeptide bands of between 100 x 10(3) and 120 x 10(3) molecular weight not present in glycoprotein extracts of uninfected cells, and these polypeptides were further purified by preparative polyacrylamide gel electrophoresis. Inoculation of chickens with purified material also resulted in the production of precipitating and neutralizing antibody, showing that these high-molecular-weight polypeptides play a role in the humoral immunity to Marek's disease. Challenge of these chickens with virulent Marek's disease virus revealed that a partial protection was afforded by the inoculated glycoproteins.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 225277      PMCID: PMC414420          DOI: 10.1128/iai.25.1.54-59.1979

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  15 in total

1.  Immunization against Marek's disease using Marek's disease virus-specific antigens free from infectious virus.

Authors:  F Lesnik; L J Ross
Journal:  Int J Cancer       Date:  1975-07-15       Impact factor: 7.396

2.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

Review 3.  Pathogenesis of Marek's disease.

Authors:  L N Payne; J A Frazier; P C Powell
Journal:  Int Rev Exp Pathol       Date:  1976

4.  T lymphoblastoid cell lines from Marek's disease lymphomas.

Authors:  P C Powell; L N Payne; J A Frazier; M Rennie
Journal:  Nature       Date:  1974-09-06       Impact factor: 49.962

5.  Two cell lines from lymphomas of Marek's disease.

Authors:  Y Akiyama; S Kato
Journal:  Biken J       Date:  1974-09

6.  Isolation from turkeys of a cell-associated herpesvirus antigenically related to Marek's disease virus.

Authors:  R L Witter; K Nazerian; H G Purchase; G H Burgoyne
Journal:  Am J Vet Res       Date:  1970-03       Impact factor: 1.156

7.  Surface antigen on chick kidney cells infected with the herpesvirus of Marek's disease.

Authors:  J H Chen; H G Purchase
Journal:  Virology       Date:  1970-02       Impact factor: 3.616

8.  Alterations of the immunological specificity of plasma membranes from cells infected with Marek's disease and turkey herpes viruses.

Authors:  O R Kaaden; B Dietzschold
Journal:  J Gen Virol       Date:  1974-10       Impact factor: 3.891

9.  Vaccination against Marek's disease: immunizing effect of purified turkey herpes virus and cellular membranes from infected cells.

Authors:  O R Kaaden; B Dietzschold; S Ueberschär
Journal:  Med Microbiol Immunol       Date:  1974-06-19       Impact factor: 3.402

10.  Insulin effect on the cell cycle: analysis of the kinetics of growth parameters in confluent chick cells.

Authors:  M H Teng; J C Bartholomew; M J Bissell
Journal:  Proc Natl Acad Sci U S A       Date:  1976-09       Impact factor: 11.205

View more
  5 in total

1.  Monospecific antibodies to Marek's disease virus antigen B dimer (200 kDa) and monomer (130 and 60 kDa) glycoproteins neutralize virus infectivity and detect the antigen B proteins in infected cell membranes.

Authors:  I Davidson; Y Becker; M Malkinson
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

2.  Identification with monoclonal antibodies of glycoproteins of Marek's disease virus and herpesvirus of turkeys related to virus neutralization.

Authors:  K Ikuta; S Ueda; S Kato; K Hirai
Journal:  J Virol       Date:  1984-03       Impact factor: 5.103

3.  Marek's disease herpesviruses. IV. Molecular characterization of Marek's disease herpesvirus A antigen.

Authors:  C Glaubiger; K Nazerian; L F Velicer
Journal:  J Virol       Date:  1983-03       Impact factor: 5.103

4.  Molecular characterization of Marek's disease herpesvirus B antigen.

Authors:  R J Isfort; I Sithole; H J Kung; L F Velicer
Journal:  J Virol       Date:  1986-08       Impact factor: 5.103

5.  Glycoprotein gp118 of varicella-zoster virus: purification by serial affinity chromatography.

Authors:  W E Friedrichs; C Grose
Journal:  J Virol       Date:  1984-03       Impact factor: 5.103

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.